Cell & Tissue Preservation Market (Type: Cells and Tissues; Application: Therapeutics, Research & Development, Drug Discovery, and Others; Product: Equipment, Bio Preservation Media, and Software; and End User: Biobanks, Hospitals, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

The global Cell & Tissue Preservation market gathered revenue around USD 4.6 billion in 2021 and market is set to grow USD 10.1 billion by the end of 2030 and is estimated to expand at a modest CAGR of 11.7% during the prediction period 2022 to 2030.

Cell & tissue preservation must be maintained at appropriate temperatures to preserve integrity of the tissue. The receiving facility is responsible for maintaining records; documenting that allograft tissue is maintained at adequate environmental requirements during transportation and stored as per the manufacturer’s recommendations for the specific tissue.

The current methods of cell & tissue preservation involve freeze-drying, deep-freezing, and cryopreservation. Each of these techniques could be utilized for storage of ligament and meniscal allografts. Deep-freezing is a highly common preservation method for ligament and meniscal allografts, entailing simply freezing the tissue to −80°C. The grafts could be preserved for 3 to 5 years. In the freeze-drying process, moisture is removed from the tissue and the graft is vacuum packaged. It could be stored at room temperature for 3 to 5 years; however, it requires rehydration before implantation. Deep-freezing and freeze-drying allograft tissue reduces immunogenicity by killing antigen-bearing cells. Cryopreservation is a process of controlled-rate freezing with extraction of cellular water by means of glycerol and dimethyl sulfoxide. This process preserves some cells and provides a 10-year shelf life.

Increase in Healthcare Expenditure

The increase in healthcare expenditure is estimated to further allow access to quality healthcare and advanced products that include biopreservation facilities, thereby broadening growth prospects. Additionally, gene banks, hospitals, and biobanks that are significant end users of the market, are encouraging most players to develop technologically advanced biopreservation products to enhance patient outcomes. The presence of government healthcare initiatives that provide funds, grants, and contracts for research has fueled R&D activities deployed by various companies. This, in turn, has boosted the scope for adoption of advanced bio-preservation services, which, in turn, is anticipated to fuel the penetration rate during the forecast period.

Rising R&D investments by companies and research communities to improve their capabilities and render efficient products & services are estimated to further create opportunities. For instance, the establishment of the Cooperative Human Tissue Network (CHTN), which addressed the operational dimension of bio-banking, exemplifies consistent efforts by the research community.

Report Scope of the Cell & Tissue Preservation Market

Market Segmentation: Cell & Tissue Preservation Market

• In terms of type, the global cell & tissue preservation market has been classified into cells and tissues. Cells have been split into mammalian cells & others (microorganisms and plant cells). The tissues segment has been categorized into blood, bone, soft tissues, skin, and others. Rise in investments in the field of regenerative medicine research is estimated to propel the market. Human blood, tissues, cells, and organs own the capability to heal damaged tissues and organs with long-term advantages.
• Based on application, the global cell & tissue preservation market has been divided into therapeutics, research & development, drug discovery, and others. Tissues preserved in tissue banks could be utilized to fulfill a variety of medical needs of people. For instance, heart valves can be used in patients with heart disorders; corneal transplantation can be used to provide vision to blind people; tendons and ligaments can be used in orthopedic surgery; and blood can be employed to treat blood disorders.
• In terms of product, the global cell & tissue preservation market has been divided into equipment, bio preservation media, and software. The equipment segment has been further sub-segmented into freezers, thawing equipment, refrigerators, storage systems, and others. While the bio preservation media segment has been further classified into home-brew media and pre-formulated media. In terms of equipment type, the cryopreservation systems segment dominated the market in 2020. Cryopreservation is the process of cooling followed by storage of frozen cells to provide a continuous supply of genetically stable living cells by inhibiting all biochemical activities that are to be used for procedures such as organ donation, bone marrow transplant, and others.
• Based on end user, the global cell & tissue preservation market has been segmented into biobanks, hospitals, and others. Biobanks store numerous different types of biospecimens, ranging from cells and small tissue samples right through to whole organs, whole limbs, or even whole bodies. Cells and small biospecimens could be flash frozen in cryoprotectant solutions and stored in liquid nitrogen to preserve their structure and function.
• Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The cell & tissue preservation market report provides current and expected revenue (US$ Mn) for each of these segments from 2022 to 2030, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2022 to 2030, along with market size estimations.

Some of the prominent players in the Cell & Tissue Preservation Market include:

• Thermo Fisher Scientific, Inc.
• Lonza
• BD
• Merck KGaA
• Cytiva
• Agilent Technologies, Inc.
• Avantor, Inc.
• FUJIFILM Irvine Scientific
• BioLifeSolutions Inc.
• AMSBIO
• Princeton CryoTech
• STEMCELL Technologies Inc.
• LGC SeraCare
• Corning Incorporated
• CellGenix GmbH

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

• Cell & Tissue Preservation Market, by Type
• Cells
• Mammalian Cells
• Others (Microorganisms and Plant Cells)
• Tissues
• Blood
• Bone
• Soft Tissues
• Skin
• Others
• Cell & Tissue Preservation Market, by Application
• Therapeutics
• Research & Development
• Drug Discovery
• Others (Cosmetics and Clinical trials)
• Cell & Tissue Preservation Market, by Product
• Equipment
• Freezers
• Thawing Equipment
• Refrigerators
• Storage Systems
• Others
• Bio Preservation Media
• Home-brew Media
• Pre-formulated Media
• Software
• Cell & Tissue Preservation Market, by End User
• Biobanks
• Hospitals
• Others

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Points Covered in Cell & Tissue Preservation Market Study:

• Growth of Cell & Tissue Preservation in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Cell & Tissue Preservation and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Cell & Tissue Preservation Consumption Analysis
•  Cell & Tissue Preservation Production Analysis
•  Cell & Tissue Preservation and Management